Millions of brain cells examined: New findings for identifying Alzheimer's symptoms

Researchers mapped over 6.3 million cell nuclei from brain tissue of 1,494 donors to compare Alzheimer's, other brain diseases, and healthy brains. The findings may aid future research on diagnosis and treatment, but this is not yet a clinical test or a new drug.

Researchers supported by the U.S. National Institutes of Health (NIH) have created a detailed map of cell activity in the brain region involved in memory and complex functions. The team examined over 6.3 million cell nuclei from brain tissue samples of 1,494 donors, including brains of people with Alzheimer's, Parkinson's, vascular dementia, and other diseases, alongside comparison samples. The comparison allowed identification of molecular processes shared by several diseases, as well as processes linked to a specific disease, Alzheimer's progression, or the onset of mental and behavioral symptoms. As part of the project, AI-powered analysis tools were also developed, and the researchers made the data and methods available to the research community. However, the article emphasizes that the gap between identifying a change in a brain cell and a treatment that helps a patient remains large, and that the study did not test a new drug or show that Alzheimer's can be diagnosed using the map. Its importance at this stage lies in a deeper understanding of the disease and creating a foundation for future studies.